June 22, 2017 12:41 PM ET

Pharmaceuticals

Company Overview of VaxOnco Inc

Company Overview

VaxOnco Inc, an oncology biopharmaceutical company, manufactures peptide based vaccines for the treatment of cancer. The company is based in Seoul, South Korea. VaxOnco Inc operates as subsidiary of GemVax & Kael Co.,Ltd.

159-3 Sam-dong

Gwangju-si

Gyeonggi-do

Seoul,  460-040

South Korea

Phone:

82 2 511 2322

Fax:

82 2 511 8242

Key Executives for VaxOnco Inc

VaxOnco Inc does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
 Chunggei Pharmaceutical Co.,Ltd. Asia
ABL Bio, Inc. Asia
AD Biotech. Co., Ltd. Asia
Ajinomoto Genexine Co., Ltd. Asia
Api Meds, Inc. Asia

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact VaxOnco Inc, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.